Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss

Acta Oto-Laryngologica

Volumn 125, Issue 12, 2005, Pages 1356-1360

  McClelland, Lisha ^a,b   Powell, Richard J ^a   Birchall, John ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b MRCS   (United Kingdom)

Author keywords

Cyclosporin A; Immunosuppression; Sudden sensorineural hearing loss

Indexed keywords

CREATININE; CYCLOSPORIN; FINASTERIDE; PREDNISOLONE; UREA;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; AUDIOLOGY; BURNING SENSATION; CASE REPORT; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FUNCTIONAL ASSESSMENT; HUMAN; HYPERTENSION; INDIGESTION; MALE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; REMISSION; SYMPTOM; UREA BLOOD LEVEL;

ADULT; ALOPECIA; AUDIOMETRY, PURE-TONE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FINASTERIDE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 28444478396     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510012372     Document Type: Article

References (16)

1. Mattox D, Simmons F. Natural history of sudden sensorineural hearing loss. Ann Otol 1997;86:463-79.
2. Sismanis A, Thompson T, Willis H. Methotrexate therapy for autoimmune hearing loss: a preliminary report. Laryngoscope 1994;104:932-4.
3. Upton H. Origin of drugs in current use: the cyclosporin story. Available from: www.world-of-fungi-org
4. Hartnick CJ, Cohen AF, Smith RV. Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3). Ann Otol Rhinol Laryngol 1997;106:640-2.
5. Harris J, Sharp P. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990;100:516-23.
6. Amor-Dorado J, Cosra-Ribas C, Gonzalez-Gay M. Autoimmunity in sudden sensorineural hearing loss [Letter to the Editor]. Acta Otolaryngol 2003;123:1115.
7. Cadoni G, Fetoni A, Agostino S, de Santis A, Manna R, Ottaviani F, et al. Autoimmunity in sudden sensorineural hearing loss: possible role of anti-endothelial cell autoantibodies. Acta Otolaryngol (Suppl) 2002;548:30-3.
8. Wilson W, Byl F, Laird N. The efficacy of steroid in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980;106:772-6.
9. Muller C, Vrabec J, Quinn F. Sudden sensorineural hearing loss. Grand Rounds presentations. Available from: www.utmb.edu/otoref/grrnds
10. Keysser G, Keysser C, Keysser M. Treatment of refractory arthritis with low-dose cyclophosphamide. Long-term follow-up of 108 patients. Zeitschrift Fur Rheumatologie 1998;57:101-7.
11. Tamesis R, Rodriguez A, Christen W, Akova Y, Messmer E, Foster C. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Opthalmology 1996;103:768-75.
12. Elidan J, Levi H, Cohen E, BenEzra D. Effect of cyclosporine A on the hearing loss in Behçet's disease. Ann Otol Rhinol Laryngol 1991;100:464-8.
13. Arinsoy T, Akpolat T, Mehmet A, Arik N, Sungur C, Yasaval U, et al. Sudden hearing loss in a cyclosporin-treated renal transplant patient. Nephron 1993;63:116-7.
14. Marioni G, Perin N, Tregnaghi A, Bellemo B, Staffieri A, de Filippis C. Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis. Acta Otolaryngol 2004;124:603-7.
15. Leitha T, Graninger W, Zagornik J. Cyclosporin A does not increase the frequency of thromboembolic events. Transplant 1988;20:436-8.
16. Palestine A, Nussenblatt R, Chan C. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984;77:652-6.